BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 28667448)

  • 1. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database.
    Hervás A; Gómez-Caamaño A; Casaña M; Gómez-Iturriaga A; Pastor J; Jove J; Mengual JL; Gónzalez-San Segundo C; Muñoz J
    Clin Transl Oncol; 2018 Feb; 20(2):193-200. PubMed ID: 28667448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database.
    Hervás A; Pastor J; González C; Jové J; Gómez A; Casaña M; Villafranca E; Mengual JL; Muñoz V; Henriquez I; Muñoz J; Collado E; Clemente J
    Clin Transl Oncol; 2019 Jul; 21(7):900-909. PubMed ID: 30536208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.
    Casas F; Valduvieco I; Oses G; Izquierdo L; Archila I; Costa M; Cortes KS; Barreto T; Ferrer F
    Clin Transl Oncol; 2019 Mar; 21(3):355-362. PubMed ID: 30128953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis benefits of adjuvant versus salvage radiotherapy for patients after radical prostatectomy with adverse pathological features: a systematic review and meta-analysis.
    Tao R; Dai J; Bai Y; Yang J; Sun G; Zhang X; Zhao J; Zeng H; Shen P
    Radiat Oncol; 2019 Nov; 14(1):197. PubMed ID: 31706339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy after radical prostatectomy for prostate cancer: clinical outcomes and factors influencing biochemical recurrence.
    Fukuda I; Aoki M; Kimura T; Ikeda K
    Ir J Med Sci; 2023 Dec; 192(6):2663-2671. PubMed ID: 37097540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
    Vogel MME; Kessel KA; Schiller K; Devecka M; Gschwend JE; Weichert W; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Nov; 14(1):198. PubMed ID: 31711524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Achieving an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome--results of a retrospective study.
    Wiegel T; Lohm G; Bottke D; Höcht S; Miller K; Siegmann A; Schostak M; Neumann K; Hinkelbein W
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1009-16. PubMed ID: 18963539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does neoadjuvant hormone therapy improve outcome in prostate cancer patients receiving radiotherapy after radical prostatectomy?
    Pai HH; Eldridge B; Bishop D; Alexander A; Lesperance M; Blood P; Lim J; Ludgate C
    Can J Urol; 2009 Apr; 16(2):4541-52. PubMed ID: 19364426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiation therapy is associated with better oncological outcome compared with salvage radiation therapy in patients with pN1 prostate cancer treated with radical prostatectomy.
    Tilki D; Preisser F; Tennstedt P; Tober P; Mandel P; Schlomm T; Steuber T; Huland H; Schwarz R; Petersen C; Graefen M; Ahyai S
    BJU Int; 2017 May; 119(5):717-723. PubMed ID: 27743493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
    Kupelian PA; Buchsbaum JC; Elshaikh M; Reddy CA; Zippe C; Klein EA
    Cancer; 2002 Dec; 95(11):2302-7. PubMed ID: 12436435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elective pelvic irradiation in prostate cancer patients with biochemical failure following radical prostatectomy: A propensity score matching analysis.
    Song C; Byun SJ; Kim YS; Ahn H; Byun SS; Kim CS; Lee SE; Kim JS
    PLoS One; 2019; 14(4):e0215057. PubMed ID: 30973905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy : Prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression.
    Lohm G; Neumann K; Budach V; Wiegel T; Hoecht S; Gollrad J
    Strahlenther Onkol; 2018 Apr; 194(4):325-332. PubMed ID: 29255924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
    Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage radiation therapy after radical prostatectomy: survival analysis.
    Galla A; Maggio A; Delmastro E; Garibaldi E; Gabriele P; Bresciani S; Di Dia A; Stasi M; Gabriele D
    Minerva Urol Nefrol; 2019 Jun; 71(3):240-248. PubMed ID: 30037205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the site of positive surgical margin in salvage external beam radiation therapy for biochemical recurrence of prostate cancer after radical prostatectomy.
    Kashihara T; Nakamura S; Wakita A; Okamoto H; Inaba K; Umezawa R; Shima S; Tsuchida K; Kobayashi K; Takahashi K; Murakami N; Ito Y; Igaki H; Fujimoto H; Uno T; Itami J
    Cancer Med; 2018 May; 7(5):1723-1730. PubMed ID: 29573193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.
    Morgan TM; Hawken SR; Ghani KR; Miller DC; Feng FY; Linsell SM; Salisz JA; Gao Y; Montie JE; Cher ML
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):216-21. PubMed ID: 26951715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant vs. salvage radiotherapy after radical prostatectomy].
    Bartkowiak D; Schrader AJ; Wiegel T
    Aktuelle Urol; 2015 Jan; 46(1):52-8. PubMed ID: 25658231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.